MBrace Therapeutics’ Post

View organization page for MBrace Therapeutics, graphic

1,695 followers

We look forward to presenting a trial in progress update for the Phase 1/1b study of MBRC-101 at #ASCO24. This clinical program demonstrates our commitment to both break new ground in #ADC innovation and bridge gaps within current #cancer treatment paradigms. Learn more: https://bit.ly/4bD5Fos

  • ASCO
Guru Sonpavde, MD

Phase I & GU Oncology Director, AdventHealth Cancer Institute; Professor of Medicine, University of Central Florida, Orlando, Florida, USA

5mo

Congrats! We would love to collaborate!

Like
Reply

To view or add a comment, sign in

Explore topics